Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.
about
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysisInterference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanolsRNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screeningDrug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screeningReduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoniA multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and BrazilA research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiasesMolecular cloning and characterization of novel glutamate-gated chloride channel subunits from Schistosoma mansoniAn artemisinin derivative of praziquantel as an orally active antischistosomal agentApplication of RNAi to Genomic Drug Target Validation in SchistosomesThe formin-homology protein SmDia interacts with the Src kinase SmTK and the GTPase SmRho1 in the gonads of Schistosoma mansoni.The contribution of mass drug administration to global health: past, present and future.Vaccines to combat the neglected tropical diseases.A PAL for Schistosoma mansoni PHM.Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.Antischistosomal effect of holothurin extracted from some Egyptian sea cucumbers.A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes.In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections.Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts.Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance.Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern EthiopiaDeworming the world.New approaches for understanding mechanisms of drug resistance in schistosomesPrevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.Prospects for the control of neglected tropical diseases by mass drug administration.Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race.Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.Hybridizations within the Genus Schistosoma: implications for evolution, epidemiology and control.What is the mechanism of action of praziquantel and how might resistance strike?Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection.Studies on the establishment of a co-culture system of lung stage Schistosoma japonicum with host cells.The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique.Artemisinin: the gifts from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.Comparative randomised trial of high and conventional doses of praziquantel in the treatment of schistosomiasis mansoni.The effect of single dose versus two doses of praziquantel on Schistosoma haematobium infection and pathology among school-aged children in Mali.Population genetics of Schistosoma haematobium: development of novel microsatellite markers and their application to schistosomiasis control in Mali.The RIO protein kinase-encoding gene Sj-riok-2 is involved in key reproductive processes in Schistosoma japonicum.Praziquantel resistance.
P2860
Q21198915-1549EAA2-1F93-484A-BF48-9B2411642053Q21562269-8F44F528-562D-4B33-9511-74516EE39977Q27306710-3E964E4A-8DB0-4681-A3F6-0B637239624EQ27306843-8DCE206B-4BF6-4101-9670-E7ABBB6FBF4DQ28475935-579F1300-1AF4-4F3B-AF95-5268A46A8EEEQ28478552-1079EEBB-B081-4C15-953F-C34FD6B5BBA2Q28482492-9A216D0F-4608-4526-A88C-740F5C70D683Q28536093-77D6E3EC-3AEB-4366-B83B-FD2D8C1D8D31Q28544852-E4178A29-60C6-4193-819B-6AB908389CE5Q28547348-DBF31D12-0AB6-4B1A-B13C-6BE85BE5D440Q30157130-50AF96E0-68D7-4209-A41E-00EADE26AD0DQ30388508-76BDD37C-B021-4EC0-806C-ED6B3FF860ABQ30425005-A2F8B5CA-A8C2-4A19-9AAA-B74B9B47802FQ34014644-37C8CBC1-5971-48A2-875D-8C64A3A30E52Q34139634-856724C8-2545-470A-8CE3-E0664CEE1969Q34225460-95803828-6F0B-4D25-A768-797A35E3681BQ34251367-3253A107-29E0-4D63-AD1E-4E9FF123B7DFQ34341901-C0FC8C93-B59D-4C22-97CF-7E34F85CF303Q35960717-4995F227-93D8-47F8-9E01-55A8C422C469Q36441487-14483DE6-8E40-4FBA-93D4-ACA2D75C4966Q36719660-2D0B1162-2F1F-489A-B6B3-6D9AA5091824Q37026044-948EA8D9-A5D6-442C-AD90-F27612766402Q37177725-26290335-4092-4413-80AF-334C699FC24FQ37360021-E88BE739-B30D-42C1-9979-8618CDA597AFQ37413446-8549B8AF-A344-4449-8DA5-D75FD7F08EADQ37557676-003FB8E7-D28F-42CA-A25F-CF7B05725E77Q38118386-A5F03D2C-93DD-428A-9832-1AF89BA04337Q38892348-0A45F7A5-43B3-42D3-B3A6-A6741756FCE4Q38940104-49D8B71A-5854-4AC7-8DCC-C4D59D542DB3Q39004186-8751A49A-8DA4-4B98-B7DE-30022431D828Q39164325-4DD82224-487D-4B35-8174-D3577E0DED0CQ39175318-1EDCF7FE-88BC-4036-970F-D4DD645576A2Q39373485-D19746A7-6B19-4F19-B163-1CBCB420CBC8Q39887622-D846A953-10FF-4FE9-ABF7-FD88F4E3B794Q42015454-A93DC09B-F3E7-43E1-8F12-DF2B1ADA7899Q42933167-639C10E1-270C-49CF-9463-79D6ABDF452AQ46090821-CEFA8EAC-2A5A-48F8-957C-ADFBF2170F16Q46188046-7D554D17-C4F3-4F48-A343-A803404C550FQ46242772-2F8E8452-9E1A-4B9B-A2F9-7BE26CA5BCFDQ46353137-6C8AA790-F0D9-4C72-8501-3BE4995667B9
P2860
Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Current status of sensitivity ...... tial drug resistance in Egypt.
@en
type
label
Current status of sensitivity ...... tial drug resistance in Egypt.
@en
prefLabel
Current status of sensitivity ...... tial drug resistance in Egypt.
@en
P2093
P921
P1476
Current status of sensitivity ...... tial drug resistance in Egypt.
@en
P2093
Hanan Sayed
James L Bennett
Maged El-Ghannam
Neimat Amer
Sanaa Botros
P304
P356
10.1016/J.IJPARA.2005.02.005
P50
P5008
P577
2005-03-18T00:00:00Z